Workflow
血栓与止血体外诊断
icon
Search documents
赛科希德股价涨5.1%,前海开源基金旗下1只基金重仓,持有13.41万股浮盈赚取22.53万元
Xin Lang Cai Jing· 2026-02-06 05:39
Group 1 - The core viewpoint of the news is that Saikexide's stock has experienced a significant increase, with a 5.1% rise on February 6, reaching a price of 34.59 yuan per share, and a total market capitalization of 3.671 billion yuan [1] - Saikexide has seen a cumulative increase of 15.55% over the past three days, indicating strong market performance [1] - The company specializes in the research, production, and sales of diagnostic instruments, reagents, and consumables in the field of thrombosis and hemostasis, with its main revenue sources being reagents (53.71%), instruments (25.40%), and consumables (20.58%) [1] Group 2 - Qianhai Kaiyuan Fund holds a significant position in Saikexide, with its Event-Driven Mixed A Fund (000423) owning 134,100 shares, accounting for 4.77% of the fund's net value, making it the third-largest holding [2] - The fund has realized a floating profit of approximately 225,300 yuan today, and a total of 594,200 yuan during the three-day increase [2] - The fund has shown a year-to-date return of 8.42% and a one-year return of 32.69%, ranking 1299 out of 8873 and 3522 out of 8123 in its category, respectively [2]
赛科希德收盘下跌1.77%,滚动市盈率21.30倍,总市值24.70亿元
Sou Hu Cai Jing· 2025-04-16 12:39
Group 1 - The core viewpoint of the article highlights the financial performance and market position of Saikohide, a company specializing in diagnostic instruments and reagents for thrombosis and hemostasis [1] - As of April 16, Saikohide's closing price was 23.27 yuan, with a rolling price-to-earnings (PE) ratio of 21.30 times, and a total market capitalization of 2.47 billion yuan [1] - The average PE ratio for the medical device industry is 45.94 times, with a median of 29.64 times, placing Saikohide at the 48th position in the industry ranking [1] Group 2 - As of the third quarter of 2024, 37 institutions hold shares in Saikohide, all of which are funds, with a total holding of 4.7493 million shares valued at 115 million yuan [1] - The company reported a revenue of 227 million yuan for the third quarter of 2024, representing a year-on-year increase of 10.89%, while net profit was 83.6587 million yuan, showing a year-on-year decrease of 4.74% [1] - The sales gross margin for Saikohide stands at 62.13% [1]